Loading…
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹1.0 CrQualified Make: Roche
Model: Evrysdi 0.75
Title: RISDIPLAM POWDER FOR ORAL SOLUTION 0.75 MG/ML (60 MG/BOTTLE) S 2 GROUND FLOOR OKHLA INDUSTRIAL AREA PHASE II NEW DELHI DELHI 110020 | SOUTH EAST DELHI | DELHI | 110020 | Make: Roche
Model: Evrysdi 0.75
Title: RISDIPLAM POWDER FOR ORAL SOLUTION 0.75 MG/ML (60 MG/BOTTLE) | L1 | Qualified MII |
Tender Value
Refer Docs
EMD Value
₹3.1 L
Closing Date
13 Feb 2025, 4:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
RISDIPLAM POWDER FOR ORAL SOLUTION 0.75 MG/ML (60 MG/BOTTLE)
7420361
GEM/2025/B/5859115
Two Packet Bid
RISDIPLAM POWDER FOR ORAL SOLUTION 0.75 MG/ML (60 MG/BOTTLE)
15 days
South West Delhi, Delhi
Total value wise evaluation
PRODUCT_CUSTOM
8 documents required · 8 mandatory
3 yrs
₹3
80%
₹3.1 L
13 Feb 2025
23 Jan 2025
13 Feb 2025
RISDIPLAM POWDER FOR ORAL SOLUTION 0.75 MG/ML (60 MG/BOTTLE)
RISDIPLAM POWDER
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7420361.pdf
GEM_BID
adobe_scan_23_jan_2025_-1_2025-01-23-14-58-25_e4946d74a89260c18db64c8c49ed3b41.pdf
SPECIFICATION
ATCDOC_d6b1115d-2283-4538-85ec1737626529040_ECHSprocurementbhdc@123.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .